SOPHiA Genetics (SOPH) Debt to Equity (2020 - 2026)
SOPHiA Genetics (SOPH) debt to equity from Mar 31, 2020 to Mar 31, 2026. The current SOPHiA Genetics (SOPH) debt to equity is 136.64%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of SOPHiA Genetics (SOPH)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 133.66% | +329.46% |
| 2024 | 31.12% | +153.40% |
| 2023 | 12.28% | +46.83% |
| 2022 | 8.36% | +76.39% |
| 2021 | 4.74% | -34.26% |
| 2020 | 7.21% | -81.03% |
| 2019 | 38.02% | +126.07% |
| 2018 | 16.82% | N/A |
Comparison SOPHiA Genetics (SOPH) debt to equity with competitors
SOPHiA Genetics (SOPH) debt to equity is 136.64%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| PHR | Phreesia Inc | 0.79% | -99.42% |
| SY | So-Young International Inc | 2.56% | -98.12% |
| HCTI | Healthcare Triangle Inc | 16.07% | -88.24% |
| CARL | Carlsmed Inc | 16.66% | -87.81% |
| OPRX | OptimizeRx Corp | 18.01% | -86.82% |
| PINC | Premier Inc - Class A | 18.32% | -86.59% |
| VSEE | VSee Health Inc | 20.66% | -84.88% |
| CERT | Certara Inc | 28.76% | -78.95% |
| WAY | Waystar Holding Corp | 37.33% | -72.68% |
| HQY | Healthequity Inc | 45.43% | -66.75% |
| DRIO | DarioHealth Corp | 49.58% | -63.71% |
| GDRX | GoodRx Holdings Inc - Class A | 78.37% | -42.65% |
| RCM | R1 RCM Inc | 78.60% | -42.48% |
| DH | Definitive Healthcare Corp - Class A | 85.34% | -37.55% |
| TBRG | Computer Programs & Systems Inc | 91.70% | -32.89% |
| HCAT | Health Catalyst Inc | 111.02% | -18.75% |
| BTSG | BrightSpring Health Services Inc | 126.20% | -7.64% |
| BTSGU | BrightSpring Health Services Inc | 126.20% | -7.64% |
| TEM | Tempus AI Inc - Class A | 195.63% | +43.18% |
| EVH | Evolent Health Inc - Class A | 245.59% | +79.73% |
| NRC | National Research Corp | 548.48% | +301.41% |